MLKL and diabetic cardiomyopathy: In summary, we have provided evidence that cardiomyocyte necroptosis plays an important role in mediating cardiac pathology of type-1 diabetes and that MLKL-mediated necroptosis contributes to diabetic cardiomyopathy.